Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial

Yoshihito Kogure, Shunichiro Iwasawa, Hideo Saka, Yoichiro Hamamoto, Akiko Kada, Hiroya Hashimoto, Shinji Atagi, Yuichi Takiguchi, Noriyuki Ebi, Akira Inoue, Takayasu Kurata, Isamu Okamoto, Masafumi Yamaguchi, Toshiyuki Harada, Masahiro Seike, Masahiko Ando, Akiko M. Saito, Kaoru Kubota, Mitsuhiro Takenoyama, Takashi SetoNobuyuki Yamamoto, Akihiko Gemma

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of carboplatin with nab-paclitaxel versus docetaxel in older patients with squamous non-small-cell lung cancer (CAPITAL): a randomised, multicentre, open-label, phase 3 trial'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases